Xcout Intel
MY01
MY01 is a medical technology company founded in 2019 and based in Montreal, Canada, that develops continuous perfusion sensing technology to help quantify diseases such as acute compartment syndrome.
Subscribe to see MY01’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
MY01 at a glance
MY01 is a medical technology company headquartered in Canada. Its most recent funding round, Series A, raised $12.5M in April 2023. Xcout tracks 7 named people at MY01, including Edward Harvey (Chairman of the Board).
MY01 leadership
- Edward HarveyChairman of the Board
- Jose de la CortinaChairman of the Board
- Charles AllanDirector
- Maria ShepherdIndependent Director
- Joe KianiBoard Member
- Louis LaflammeBoard Member
1 more named person on record for MY01, with roles, board committees and tenure — see the full roster →
MY01 funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $12.5M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
MY01 competitors
A few of MY01's closest competitors — see the full list of competitors and alternatives →
Flosonics Medical is a venture-backed medical device company founded in 2015 and based in Toronto. The company develops and commercializes non-invasive, wearable ultrasound sensors, including the FloPatch, to provide real-time hemodynamic assessments for the clinical management of critically ill patients.
Luciole Medical AG is a Swiss medical technology company founded in 2007 and headquartered in Zurich, Switzerland, specializing in cerebral monitoring solutions.
DiaMonTech is an innovative medical technology company based in Berlin that develops non-invasive, pain-free glucose monitoring solutions for everyday diabetes management.
MediBeacon LLC is a medical technology company that develops fluorescent tracer agents and transdermal detection systems for physiological monitoring and organ function assessment. The company serves clinical and preclinical markets, focusing on applications in nephrology, gastroenterology, ophthalmology, and surgery.
Sava Technologies develops a minimally invasive biosensor platform designed for real-time continuous health monitoring beyond glucose alone, including metrics like lactate, ketones, and cortisol. The company provides affordable, multi-molecule detection technology aimed at managing chronic conditions and general wellbeing.
EarlySense is an Israeli healthtech company that develops contact-free patient-monitoring systems using sensors placed under a mattress or seat to track vital signs and movement. Its solutions are used by hospitals and other healthcare providers for continuous monitoring, early detection of patient deterioration, and fall-risk management.
Get MY01's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on MY01 in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access